Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 9Other 4Thoracic 3Other solid neoplasm 3Lymphoid 3Tumor-Agnostic 2Other neoplasm 2Gynecologic 2Plasma cell 1Head & Neck 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Uterine Cervical Neoplasms 1Squamous Intraepithelial Lesions 1Precancerous Conditions 1Papillomavirus Infections 1Ovarian Neoplasms 1Hot Flashes 1Atypical Squamous Cells of the Cervix 1

Interventions

Paclitaxel 575Carboplatin 520Cisplatin 347Bevacizumab 252pembrolizumab 226Gemcitabine 157Topotecan 128liposomal doxorubicin 127Cyclophosphamide 126olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 80niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 56Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Mindfulness-Based Stress Reduction × Gynecologic × Clear all
NCT02372864 2017-10-26

PURSUE

University Medical Center Groningen

Phase NA Completed
66 enrolled
Gynecologic

Ovarian Neoplasms, Hot Flashes

NCT00653146 2016-12-05

The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia

Fox Chase Cancer Center

Phase NA Completed
186 enrolled
GynecologicOther neoplasm

Squamous Intraepithelial Lesions, Uterine Cervical Neoplasms, Precancerous Conditions, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡